A recent study utilized an exome sequencing screen to characterize the functional impact of FBXW7 mutations in melanoma, and highlight its substrate NOTCH1 as a suitable therapeutic marker in the clinical setting. This evidence concerns the gene NOTCH1 and melanoma.